Education
About Us
Working with TipRanks
Follow Us
PROCEPT BioRobotics (PRCT)
NASDAQ:PRCT
Total Valuation
PROCEPT BioRobotics has a market cap or net worth of $3.35B. The enterprise value is $1.70B.
Market Cap$3.35B
Enterprise Value$1.70B
Share Statistics
PROCEPT BioRobotics has 55,328,667 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding55,328,667
Owned by Insiders2.98%
Owned by Institutions23.34%
Financial Efficiency
PROCEPT BioRobotics’s return on equity (ROE) is -0.23 and return on invested capital (ROIC) is -20.01%.
Return on Equity (ROE)-0.23
Return on Assets (ROA)-0.17
Return on Invested Capital (ROIC)-20.01%
Return on Capital Employed (ROCE)-0.20
Revenue Per Employee296.96K
Profits Per Employee-120.92K
Employee Count756
Asset Turnover0.42
Inventory Turnover1.56
Valuation Ratios
The current PE Ratio of PROCEPT BioRobotics is -45.91. PROCEPT BioRobotics’s PEG ratio is -0.41.
PE Ratio-45.91
PS Ratio0.00
PB Ratio9.36
Price to Fair Value10.43
Price to FCF-22.21
Price to Operating Cash Flow-22.95
PEG Ratio-0.41
Income Statement
In the last 12 months, PROCEPT BioRobotics had revenue of 224.50M and earned -91.41M in profits. Earnings per share was -1.75.
Revenue224.50M
Gross Profit137.10M
Operating Income-96.61M
Pretax Income-91.41M
Net Income-91.41M
EBITDA-82.00M
Earnings Per Share (EPS)-1.75
Cash Flow
In the last 12 months, operating cash flow was -83.91M and capital expenditures -4.30M, giving a free cash flow of -88.21M billion.
Operating Cash Flow-83.91M
Free Cash Flow-88.21M
Free Cash Flow per Share-1.59
Dividends & Yields
PROCEPT BioRobotics pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.41
52-Week Price Change-2.27%
50-Day Moving Average56.05
200-Day Moving Average71.94
Relative Strength Index (RSI)53.58
Average Volume (3m)832.68K
Important Dates
PROCEPT BioRobotics upcoming earnings date is Jul 31, 2025, TBA Not Confirmed.
Last Earnings DateApr 24, 2025
Next Earnings DateJul 31, 2025
Ex-Dividend Date―
Financial Position
PROCEPT BioRobotics as a current ratio of 9.07, with Debt / Equity ratio of 39.23%
Current Ratio9.07
Quick Ratio8.01
Debt to Market Cap0.01
Net Debt to EBITDA3.09
Interest Coverage Ratio-23.09
Taxes
In the past 12 months, PROCEPT BioRobotics has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
PROCEPT BioRobotics EV to EBITDA ratio is -48.10, with an EV/FCF ratio of -38.06.
EV to Sales17.57
EV to EBITDA-48.10
EV to Free Cash Flow-38.06
EV to Operating Cash Flow-39.75
Balance Sheet
PROCEPT BioRobotics has $316.21M in cash and marketable securities with $79.81M in debt, giving a net cash position of -$236.39M billion.
Cash & Marketable Securities$316.21M
Total Debt$79.81M
Net Cash-$236.39M
Net Cash Per Share-$4.27
Tangible Book Value Per Share$7.70
Margins
Gross margin is 49.44%, with operating margin of -43.04%, and net profit margin of -40.72%.
Gross Margin49.44%
Operating Margin-43.04%
Pretax Margin-40.72%
Net Profit Margin-40.72%
EBITDA Margin-36.52%
EBIT Margin-38.86%
Analyst Forecast
The average price target for PROCEPT BioRobotics is $80.20, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$80.20
Price Target Upside32.28% Upside
Analyst ConsensusStrong Buy
Analyst Count10
Revenue Growth Forecast59.36%
EPS Growth Forecast19.87%